Fukuoka, Kurume, Japan Clinical Trials

A listing of Fukuoka, Kurume, Japan clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 64 clinical trials
Evaluate the Safety and Tolerability for Nirsevimab in Immunocompromised Children

Study D5290C00008 is a Phase 2, open-label, uncontrolled, single-dose study to evaluate the safety and tolerability, PK, occurrence of ADA, and efficacy of nirsevimab in immunocompromised Japanese children who are 24 months of age at the time of dose administration. Approximately 30 subjects will be enrolled. Subjects will be followed …

wiskott-aldrich syndrome
corticosteroid therapy
Research Site
 (0.6 away) Contact site
  • 20 Jul, 2021
  • +8 other locations
A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic People With Schizophrenia Followed by an Open-label Extension Phase

A clinical study to investigate the effect of 2 doses of an investigational drug in acutely psychotic adult patients with schizophrenia. The study will consist of a double-blind phase followed by an open-label extension phase.

NHO Hizen Psychiatric Center
 (7.7 away) Contact site
  • 11 Apr, 2021
  • +24 other locations
An Extension Study of TAK-664 for Japanese People With Primary Immunodeficiency Disease

This study is an extension study for participants with primary immunodeficiency disorders who were previously treated with IGSC, 20% in the TAK-664-3001 study. They must have completed that study or be about to complete it before joining this study. Participants will continue treatment with IGCS, 20% in this study. The …

Kurume University Hospital
 (0.6 away) Contact site
  • 24 Sep, 2021
  • +7 other locations
Study of Zanubrutinib in Japanese Participants With B-Cell Malignancies

This is a Phase 1/2 study of zanubrutinib in Japanese participants with mature B-cell malignancies. This study intends to assess the use of zanubrutinib as an investigational agent to develop new treatment options for Japanese participants with B-cell malignancies. No formal hypothesis testing will be performed given the small sample …

Kurume University Hospital
 (0.6 away) Contact site
  • 01 Mar, 2021
  • +14 other locations